Aurinia Pharmaceuticals

NasdaqGM:AUPH Stock Report

Mkt Cap: US$665.1m

Aurinia Pharmaceuticals Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

NasdaqGM:AUPH Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
21 Nov 22BuyUS$46,600Matthew DonleyIndividual10,000US$4.66
09 Nov 22BuyUS$25,075Scott HabigIndividual5,000US$5.02
07 Nov 22BuyUS$154,800Michael MartinIndividual30,000US$5.16
09 Mar 22BuyUS$54,985R. Mackay-DunnIndividual5,000US$11.00
04 Mar 22BuyUS$54,100George MilneIndividual5,000US$10.82
02 Mar 22SellUS$58,236Robert HuizingaIndividual4,849US$12.01
02 Mar 22SellUS$58,200Neil SolomonsIndividual4,846US$12.01
02 Mar 22SellUS$38,492Massimiliano ColaoIndividual3,205US$12.01
02 Mar 22SellUS$58,236Michael MartinIndividual4,849US$12.01
02 Mar 22SellUS$108,907Peter GreenleafIndividual9,068US$12.01
02 Mar 22SellUS$36,751Joseph MillerIndividual3,060US$12.01
02 Mar 22SellUS$36,655Matthew DonleyIndividual3,052US$12.01
28 Feb 22BuyUS$2,350,000ILJIN SNT Co., LtdCompany200,000US$11.75
13 Dec 21BuyUS$32,064Jill LeversageIndividual1,600US$20.04
13 Dec 21BuyUS$32,064Jill LeversageIndividual1,600US$20.04

Insider Trading Volume

Insider Buying: AUPH insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of AUPH?
Owner TypeNumber of SharesOwnership Percentage
Public Companies1,123,6080.8%
Individual Insiders2,552,5551.8%
VC/PE Firms7,841,5705.5%
Institutions56,180,99539.5%
General Public74,410,97552.4%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 9.6%.


Top Shareholders

Top 25 shareholders own 38.36% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
5.52%
Deep Track Capital, LP
7,841,570$36.7m38.12%1.59%
5.43%
BlackRock, Inc.
7,713,055$36.1m-1.26%no data
4.02%
ILJIN SNT Co., Ltd
5,708,712$26.7m0%no data
3.51%
FMR LLC
4,994,605$23.4m2.15%no data
2.79%
New Enterprise Associates, Inc.
3,969,834$18.6m0%0.88%
2%
Bellevue Asset Management AG
2,846,457$13.3m6.55%0.14%
1.94%
Citadel Advisors LLC
2,750,116$12.9m216.38%0.02%
1.72%
State Street Global Advisors, Inc.
2,441,434$11.4m2.24%no data
1.02%
Chin-Kyu Huh
1,445,480$6.8m0%no data
1.02%
Morgan Stanley, Investment Banking and Brokerage Investments
1,443,163$6.8m-49.57%no data
0.85%
The Vanguard Group, Inc.
1,207,609$5.7m3.31%no data
0.85%
Geode Capital Management, LLC
1,204,982$5.6m3.56%no data
0.79%
ILJIN Holdings Co., Ltd.
1,123,608$5.3m0%no data
0.75%
Rock Springs Capital Management LP
1,066,408$5.0m30.83%0.13%
0.71%
Northern Trust Global Investments
1,004,868$4.7m-1.42%no data
0.7%
Artal Group S.A.
1,000,000$4.7m0%0.26%
0.68%
Stifel Asset Management Corp.
967,931$4.5m-7.07%0.01%
0.6%
Balyasny Asset Management L.P.
853,787$4.0m71.01%0.01%
0.6%
Citigroup Inc.,Banking and Securities Investments
850,680$4.0m-1.28%no data
0.55%
Susquehanna International Group, LLP, Asset Management Arm
776,381$3.6m-54.78%0.01%
0.52%
Renaissance Technologies LLC
733,800$3.4m22.59%no data
0.51%
Armistice Capital LLC
724,000$3.4m0%0.08%
0.45%
Dennis Bourgeault
637,950$3.0m0%no data
0.44%
Barclays PLC Private Banking & Investment Banking Investment
630,250$2.9m-38.42%no data
0.4%
SV Health Investors, LLC
573,530$2.7m0%0.67%